Search Tag: clinical-stage biotechnology
2022 04 Oct
Kineta, Inc, a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology announced the appointment of Keith Baker as the Company’s new Chief Financial Officer (CFO). “It is a pleasure to welcome Keith to our management team at this pivotal time for Kineta,” said Shawn Iadonato, Ph.D., Chief Executive Officer...Read more
2022 12 Apr
Cardiff Oncology, Inc., a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers has announced that Katherine L. Ruffner , M.D., chief medical officer (CMO), will be leaving the Company on April 22, 2022 , to pursue a new opportunity. Dr. Ruffner will provide Cardiff Oncology with transitional...Read more